Bioventix (BVXP) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.402x

Based on the latest financial reports, Bioventix (BVXP) has a cash flow conversion efficiency ratio of 0.402x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX4.44 Million ≈ $539.88 USD) by net assets (GBX11.04 Million ≈ $1.34K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BVXP cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Bioventix - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Bioventix's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bioventix Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioventix ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Metavisio (Thomson Computing) PA:ALTHO	0.002x
MultiMetaVerse Holdings Limited NASDAQ:MMV	0.007x
Octopus Aim Vct Plc LSE:OOA	-0.006x
Strix Group Plc LSE:KETL	0.250x
Stelmine Canada Ltd V:STH	0.019x
Rover Metals Corp V:ROVR	-0.003x
Record PLC LSE:REC	0.126x
Spectra Systems Corp LSE:SPSY	-0.016x

Annual Cash Flow Conversion Efficiency for Bioventix (2011–2025)

The table below shows the annual cash flow conversion efficiency of Bioventix from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Bioventix market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX11.55 Million ≈ $1.41K	GBX7.03 Million ≈ $855.57	0.609x	-12.44%
2024-06-30	GBX12.00 Million ≈ $1.46K	GBX8.34 Million ≈ $1.02K	0.695x	+6.11%
2023-06-30	GBX12.06 Million ≈ $1.47K	GBX7.90 Million ≈ $961.62	0.655x	+2.42%
2022-06-30	GBX11.82 Million ≈ $1.44K	GBX7.56 Million ≈ $920.03	0.640x	+18.74%
2021-06-30	GBX11.82 Million ≈ $1.44K	GBX6.37 Million ≈ $774.79	0.539x	-12.67%
2020-06-30	GBX12.52 Million ≈ $1.52K	GBX7.72 Million ≈ $939.79	0.617x	+13.63%
2019-06-30	GBX10.83 Million ≈ $1.32K	GBX5.88 Million ≈ $715.12	0.543x	+0.94%
2018-06-30	GBX11.01 Million ≈ $1.34K	GBX5.92 Million ≈ $720.55	0.538x	+37.89%
2017-06-30	GBX10.14 Million ≈ $1.23K	GBX3.96 Million ≈ $481.44	0.390x	+0.93%
2016-06-30	GBX8.21 Million ≈ $998.60	GBX3.17 Million ≈ $385.91	0.386x	+18.62%
2015-06-30	GBX6.58 Million ≈ $801.10	GBX2.15 Million ≈ $260.99	0.326x	-3.36%
2014-06-30	GBX5.24 Million ≈ $637.09	GBX1.77 Million ≈ $214.78	0.337x	+5.70%
2013-06-30	GBX4.20 Million ≈ $511.61	GBX1.34 Million ≈ $163.17	0.319x	-14.04%
2012-06-30	GBX3.34 Million ≈ $406.34	GBX1.24 Million ≈ $150.76	0.371x	+29.66%
2011-06-30	GBX2.68 Million ≈ $325.76	GBX766.14K ≈ $93.22	0.286x	--

About Bioventix

LSE:BVXP UK Biotechnology

Market Cap

$1.11 Million

GBX9.12 Billion GBX

Market Cap Rank

#30448 Global

#792 in UK

Share Price

GBX1745.00

Change (1 day)

-4.38%

52-Week Range

GBX1375.00 - GBX3020.00

All Time High

GBX4868.77